Role of follistatin-like protein 1 in liver diseases
Related Experiment Video
Updated: Aug 16, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Chuansha Gu1, Hua Xue2, Xiaoli Yang1
1Xinxiang Key Laboratory of Tumor Microenvironment and Immunotherapy, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Abstract:
Liver diseases, including viral hepatitis, fatty liver, metabolic-associated fatty liver disease, liver cirrhosis, alcoholic liver disease, and liver neoplasms, are major global health challenges. Despite the continued development of new drugs and technologies, the prognosis of end-stage liver diseases, including advanced liver cirrhosis and liver neoplasms, remains poor. Follistatin-like protein 1 (FSTL1), an extracellular glycoprotein, is secreted by various cell types. It is a glycoprotein that belongs to the family of secreted proteins acidic and rich in cysteine (SPARC). It is also known as transforming growth factor-beta inducible TSC-36 and follistatin-related protein (FRP). FSTL1 plays a key role in cell survival, proliferation, differentiation, and migration, as well as the regulation of inflammation and immunity. Studies have demonstrated that FSTL1 significantly affects the occurrence and development of liver diseases. This article reviews the role and mechanism of FSLT1 in liver diseases.
Insights
Follistatin-like protein 1 (FSTL1) is crucial in liver disease development. Understanding FSTL1
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Liver diseases pose significant global health challenges.
- End-stage liver diseases like cirrhosis and cancer have poor prognoses.
- Follistatin-like protein 1 (FSTL1) is an extracellular glycoprotein involved in cellular processes.
Purpose of the Study:
- To review the role and mechanisms of Follistatin-like protein 1 (FSTL1) in liver diseases.
- To highlight FSTL1's impact on the occurrence and progression of various liver conditions.
Main Methods:
- Literature review of studies investigating Follistatin-like protein 1 (FSTL1) in liver disease.
- Analysis of FSTL1's functions in cell survival, proliferation, differentiation, migration, inflammation, and immunity.
Main Results:
- Follistatin-like protein 1 (FSTL1) significantly influences the development of liver diseases.
- FSTL1 plays a key role in regulating cellular functions relevant to liver health and disease.
Conclusions:
- Follistatin-like protein 1 (FSTL1) is a critical factor in liver disease pathogenesis.
- Further research into FSTL1 mechanisms may offer new therapeutic strategies for liver diseases.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Cell Specific Gene Expression
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):

